ENLV
Enlivex Therapeutics·NASDAQ
--
--(--)
--
--(--)
ENLV Filings
Filing Date
Form Description
Form Type
2026-02-05
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-02-05 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-01-26
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-01-26 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-01-23
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-01-23 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-01-07
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-01-07 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-01-06
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-01-06 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-01-05
Form EFFECT - Notice of Effectiveness
2026-01-05 ·
Form EFFECT - Notice of Effectiveness
2025-12-23
Form F-3 - Registration statement by foreign private issuers
2025-12-23 ·
Form F-3 - Registration statement by foreign private issuers
2025-12-18
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-12-18 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-12-04
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-12-04 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-11-26
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-11-26 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
